Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
300 participants
OBSERVATIONAL
2019-07-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Effects in Overweight Patients
NCT00493012
Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D
NCT01585051
Effect of Vitamin D3 Supplementation on Cardiometabolic Risk
NCT02359214
Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19
NCT04825093
Vitamin D and Type 2 Diabetes Study
NCT01942694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal weight and overweight adults
Association between vitamin D levels and insulin resistance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males and females
* 18-50 years
Exclusion Criteria
* HbA1c \> 6.4%
* Pregnancy
* Diagnosis of liver disease (including liver enzymes \> 3 times above normal values)
* Diagnosis of renal disease (creatinine of \> 150 mmol/l)
* Post-menopausal women
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liverpool Hope University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grace Farhat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Health sciences
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7062019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.